Wolwo Pharma(SZ:300357) Xin Lang Cai Jing·2025-10-28 05:29Group 1 - Iwubio's stock price increased by 5.17% on October 28, reaching 34.79 CNY per share, with a trading volume of 392 million CNY and a turnover rate of 2.37%, resulting in a total market capitalization of 18.215 billion CNY [1] - The stock has risen for three consecutive days, with a cumulative increase of 4.58% during this period [1] - Iwubio, established on September 19, 2002, and listed on January 21, 2014, specializes in the research, production, and sales of products for the diagnosis and treatment of allergic diseases [1] Group 2 - The main revenue sources for Iwubio include dust mite drops (94.17%), Artemisia annua flowers (4.35%), skin prick solution (1.31%), research services (0.12%), and others (0.05%) [1] - Among the top ten circulating shareholders, a fund under Harvest Fund Management, Harvest Mutual Selected Stock A (006603), entered the list in the third quarter, holding 4.7118 million shares, which is 0.97% of the circulating shares [2] - The estimated floating profit for the fund today is approximately 8.0572 million CNY, with a floating profit of 6.8321 million CNY during the three-day increase [2] Group 3 - The fund manager of Harvest Mutual Selected Stock A is Hao Miao, who has been in the position for 6 years and 287 days, managing a total fund size of 5.342 billion CNY [3] - During his tenure, the best fund return was 183.83%, while the worst return was -30.55% [3]